Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/15/2000EP0984937A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984936A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984934A1 Novel orally active iron (iii) chelators
03/15/2000EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity
03/15/2000EP0984928A1 Aromatic and heterocyclic nitrato derivatives
03/15/2000EP0984915A2 Lutein esters having high bioavailability
03/15/2000EP0984790A1 Herpes simplex virus vp22 vaccines and methods of use
03/15/2000EP0984787A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
03/15/2000EP0984786A1 Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
03/15/2000EP0984785A1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
03/15/2000EP0984784A2 Anti-cancer products for treating cystic fibrosis
03/15/2000EP0984783A1 Anthelmintic compositions
03/15/2000EP0984782A2 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases
03/15/2000EP0984781A1 Analgesic drug composition containing a capsaicinoid and potentiator therefor
03/15/2000EP0984780A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
03/15/2000EP0984779A1 Somatostatin agonists
03/15/2000EP0984778A1 Neuropeptide-y ligands
03/15/2000EP0984777A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
03/15/2000EP0984774A1 Gastroretentive controlled release microspheres for improved drug delivery
03/15/2000EP0984773A1 Pharmaceutical formulation of omeprazole
03/15/2000EP0984692A1 Novel angiogenesis inhibitors
03/15/2000EP0904070B1 The use of buckminsterfullerene for treatment of neurotoxic injury
03/15/2000EP0850232B1 Benzothiazolone derivatives
03/15/2000EP0814780A4 Diltiazem controlled release formulation
03/15/2000EP0806943B1 Valaciclovir tablets containing colloidal silicon dioxide
03/15/2000EP0797579B1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
03/15/2000EP0783504B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS
03/15/2000EP0769901B1 Two-and three-component fungicidal mixtures
03/15/2000EP0753063B1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
03/15/2000EP0742022B1 Biologically compatible hydrogel
03/15/2000EP0729756B1 Granular preparation
03/15/2000EP0667351B1 Compound uch9
03/15/2000EP0664802B1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders
03/15/2000EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
03/15/2000EP0648279B1 Acceptor for fucosyltransferase
03/15/2000EP0633787B1 Use of ibuprofen-beta-cyclodextrin complex for oral consumption
03/15/2000EP0619805B1 5-(hetero- or carbocyclylamino)-indole derivatives, their preparation and their use as 5-ht1 agonists
03/15/2000EP0618797B1 Pharmaceutical preparations containing bilobalid for the treatment of nervous tension and anxiety
03/15/2000EP0572615B1 Medicament for the Treatment of Protozoal Infections caused by Babesia
03/15/2000EP0567566B1 Methods for treating tumor necrosis factor mediated diseases
03/15/2000EP0559804B1 Diaper rash treatment
03/15/2000EP0550580B1 Uracil reductase inactivator
03/15/2000EP0549702B1 Use of recombinant colony stimulating factor-1
03/15/2000EP0533703B1 Use of steroids for the inhibition of angiogenesis
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247542A Serine protease inhibitors
03/15/2000CN1247541A Steroids substituted in position 11, method of prepn. application as medicines and pharmaceutical compsns. containing them
03/15/2000CN1247539A Process for preparing eprosartan
03/15/2000CN1247537A Sulfonamide compounds having 5-HT receptor activity
03/15/2000CN1247534A Benzofurazan compounds which enhance AMPA receptor activity
03/15/2000CN1247533A Heterocyclic carboxylic acid derivatives, prodn. and use thereof as endothelin receptor antagonists
03/15/2000CN1247531A Arylsulfonyl hydroxamic acid derivatives
03/15/2000CN1247530A Acrylonitrile compounds, process for their prodn. and pesticides containing them
03/15/2000CN1247473A Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
03/15/2000CN1247471A Oxacarbazepine filme-coated tablets
03/15/2000CN1247470A Method of using cycloxygenase-2 inhibitors as anti-angiogenic agents
03/15/2000CN1247469A Drugs inhibiting progress of pterygium and postoperative recurrence of same
03/15/2000CN1247228A Human pluripotent leukosis cell differentiated correlative gene
03/15/2000CN1247191A Imidazolium compound as synthetic material of imidazole lipoxidase inhibitor
03/15/2000CN1247077A Medical oil for treating burn and scald and its preparing process
03/15/2000CN1247074A Medical capsules for treating arthritides and its preparing process
03/15/2000CN1247066A Internally applied veterinary drug for treating pig's parasitosis
03/15/2000CN1247064A Compound urea drops for ear
03/15/2000CN1247063A Ear drops
03/15/2000CN1247059A Non-saccharide nutritive amino acid liquid
03/15/2000CN1050365C Method for prepn. of hexan-2-olefin pyranoseoside of alcohol and phenol
03/15/2000CN1050364C 7-glycosyloxybenzopyran derivative and antiallergic agent
03/15/2000CN1050361C Light-filtering agent, sun-screening cosmetic compsns. containing said light-filtering agent and usage thereof
03/15/2000CN1050359C Diterpene salicylate alkaloid, prepn. and use thereof
03/15/2000CN1050358C New tetracyclic piperidine and 1,4-oxazine compounds, its prepn. and pharmaceutical compsns. containing them
03/15/2000CN1050286C Application of cucoline in preparing medicine for treating chronic nephritis
03/15/2000CN1050285C Method for prepn. of pressurised aerosol compositions
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000USRE36617 (Substituted aralkyl) heterocyclic compounds
03/14/2000US6037488 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
03/14/2000US6037481 Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment
03/14/2000US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis
03/14/2000US6037470 Purine compounds having PDE IV inhibitory activity and methods of synthesis
03/14/2000US6037469 Beta lactamase inhibitor and antibacterial; for treating bacterial infections in humans and animals
03/14/2000US6037467 Methods for preparing carbohydrate-containing hydrophilic polymers
03/14/2000US6037386 Latex barrier having polymer matrix comprising zinc oxide or zinc gluconate gel irritant deactivating agent; condoms, gloves
03/14/2000US6037379 Administering z-2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol
03/14/2000US6037377 Antiinflammatory agents and antiallergens
03/14/2000US6037376 Methods for therapy of cancer
03/14/2000US6037373 Treating nervous system, cytological, hormonal, gastrointestinal and liver disorders
03/14/2000US6037372 Anticarcinogenic agents, viricides
03/14/2000US6037370 Methods and compositions for stimulating neurite growth
03/14/2000US6037369 Administering caffeic acid or b-(3,4-dihydroxyphenyl)-lactic acid conjugate
03/14/2000US6037368 8-iso- prostaglandins for glaucoma therapy
03/14/2000US6037364 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
03/14/2000US6037362 Carbazole derivatives; deprotecting, amination; antilipemic and antidiabetic agents; b-adrenaline receptor agonists; dietetics
03/14/2000US6037361 Fluorinated butyric acids and their derivatives as inhibitors of matrix metalloproteinases
03/14/2000US6037360 Side effect reduction; treating sexual disorders
03/14/2000US6037359 Isoxazolidinedione derivatives and use thereof
03/14/2000US6037358 Decongestant/antihistaminic compositions
03/14/2000US6037357 Antitumor and antimetastasis agents
03/14/2000US6037356 Anticoagulants; antiinflammatory and antiarthritic agents
03/14/2000US6037355 Imidazole lipoxygenase inhibitors
03/14/2000US6037353 Administering terfenadine acid derivative; cardiac side effect reduction
03/14/2000US6037352 N-substituted piperidine derivatives; treating alzheimer*s disease, nervous system disorders; acetylcholinesterase inhibitors
1 ... 6349 6350 6351 6352 6353 6354 6355 6356 6357 6358 6359 6360 6361 6362 6363 6364 6365 6366 6367 6368 6369 ... 7860